AGP Executive Report
Last update: 5 hours agoStroke Risk: A new population study finds first-ever stroke incidence among adults 20–54 nearly doubled in Greater Cincinnati/Northern Kentucky from the early 1990s to 2020, driven mainly by ischemic strokes even as 30-day fatality fell. FDA Approvals: The FDA cleared zilurgisertib (Atebrioz) for fibrodysplasia ossificans progressiva in patients 12+ and approved obinutuzumab (Gazyva) for idiopathic nephrotic syndrome; it also approved Welireg plus Lenvima for advanced clear cell renal cell carcinoma after PD-1/PD-L1 therapy. Diabetes Care: Once-weekly basal insulin options expanded again with FDA approval of insulin efsitora alfa-gobe (Onswik), with trial results showing noninferior A1C control and hypoglycemia differences in insulin-naive patients. Health IT & Access: Oracle Health is integrating ID.me digital identity to streamline patient portal check-in and record sharing; Ingenio Care launched a marketplace using CMS data to help patients compare cost and quality. Public Health & Safety: UNICEF warns acute malnutrition is rising sharply in Yemen amid conflict; Ohio indicted 18 Medicaid providers for fraud totaling $355,000+. Equity & Inclusion: The deaf community is calling for stronger recognition of sign language and equal access to services. Local Impact: Harnett County’s Board of Health received a top state award, and a Vasai-Virar initiative will provide free meals for patients under a health scheme.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
